Additionally, it has previously been demonstrated that different states of PSA levels such as increasing, stable and decreasing affected prostate cancer–specific anxiety, demonstrating the need for measuring timepoints around PSA blood tests and at more regular intervals. This evidence concerns the gene KLK3 and prostate cancer.